High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM
Clinical trial NCT06045286 · UNKNOWN
Trial details
- NCT number
- NCT06045286
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2024-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.